Tvardi Therapeutics Stock Price, News & Analysis
TVRD
NASDAQ
Company Description
Welcome to the overview page for Tvardi Therapeutics (TVRD), where you can find comprehensive stock information and company updates.
Explore the latest news on strategic partnerships, quarterly and annual financial results, and regulatory filings including SEC reports and insider transactions.
Visualize performance trends using the interactive price chart, and keep track of upcoming events such as earnings calls, dividend dates, and investor conferences.
Stock Performance
$6.88
+2.84%
+0.19
Last updated: October 13, 2025 at 19:09
59.41 %
Performance 1 year
$390.1M
9.4M
Latest News
SEC Filings
Financial Highlights
$0
Revenue (TTM)
$4,167,000
Net Income (TTM)
-$1.00
-$8,865,000
Operating Cash Flow
4.04
-$8,869,000
Upcoming Events
JAN
01
January 1, 2026
Clinical
Liver cancer trial preliminary data
JAN
01
January 1, 2026 - June 30, 2026
Clinical
TTI-109 topline data
Preliminary TTI-109 healthy-volunteer topline data release
JAN
01
January 1, 2026 - June 30, 2026
Clinical
TTI-101 HCC Phase 2 data
Release of TTI-101 Phase 2 hepatocellular carcinoma data
Short Interest History
Last 12 Months
Loading short interest data...
Days to Cover History
Last 12 Months
Loading days to cover data...
Frequently Asked Questions
What is the current stock price of Tvardi Therapeutics (TVRD)?
The current stock price of Tvardi Therapeutics (TVRD) is $6.69 as of October 13, 2025.
What is the market cap of Tvardi Therapeutics (TVRD)?
The market cap of Tvardi Therapeutics (TVRD) is approximately 390.1M. Learn more about what market capitalization means .
What is the revenue (TTM) of Tvardi Therapeutics (TVRD) stock?
The trailing twelve months (TTM) revenue of Tvardi Therapeutics (TVRD) is $0.
What is the net income of Tvardi Therapeutics (TVRD)?
The trailing twelve months (TTM) net income of Tvardi Therapeutics (TVRD) is $4,167,000.
What is the earnings per share (EPS) of Tvardi Therapeutics (TVRD)?
The diluted earnings per share (EPS) of Tvardi Therapeutics (TVRD) is -$1.00 on a trailing twelve months (TTM) basis. Learn more about EPS .
What is the operating cash flow of Tvardi Therapeutics (TVRD)?
The operating cash flow of Tvardi Therapeutics (TVRD) is -$8,865,000. Learn about cash flow.
What is the current ratio of Tvardi Therapeutics (TVRD)?
The current ratio of Tvardi Therapeutics (TVRD) is 4.04, indicating the company's ability to pay short-term obligations. Learn about liquidity ratios.
What is the operating income of Tvardi Therapeutics (TVRD)?
The operating income of Tvardi Therapeutics (TVRD) is -$8,869,000. Learn about operating income.